HemoTypeSC
Hemoglobinopathy Screening (Sickle Cell Disease/Trait)
Key Facts
About Silver Lake Research
Silver Lake Research is a long-established, privately-held diagnostics company specializing in lateral flow rapid tests powered by its proprietary EAP™ monoclonal antibody platform. The company has a commercial portfolio targeting areas like hemoglobinopathy screening (HemoTypeSC), water safety, and urinary tract infection detection (RapidBac™), and offers significant contract development and manufacturing (CDMO) services. With over 150 products marketed and 15 million+ test strips sold, Silver Lake leverages its integrated US-based capabilities for both its own branded products and private-label/contract manufacturing for partners. Its strategy is built on the unique specificity of its antibodies, turnkey manufacturing solutions, and a focus on point-of-care diagnostics.
View full company profile